Living Autologous Heart Valves Engineered From Human Prenatally Harvested Progenitors
- 4 July 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 114 (1_suppleme) , I125-31
Abstract
Background— Heart valve tissue engineering is a promising strategy to overcome the lack of autologous growing replacements, particularly for the repair of congenital malformations. Here, we present a novel concept using human prenatal progenitor cells as new and exclusive cell source to generate autologous implants ready for use at birth. Methods and Results— Human fetal mesenchymal progenitors were isolated from routinely sampled prenatal chorionic villus specimens and expanded in vitro. A portion was cryopreserved. After phenotyping and genotyping, cells were seeded onto synthetic biodegradable leaflet scaffolds (n=12) and conditioned in a bioreactor. After 21 days, leaflets were endothelialized with umbilical cord blood-derived endothelial progenitor cells and conditioned for additional 7 days. Resulting tissues were analyzed by histology, immunohistochemistry, biochemistry (amounts of extracellular matrix, DNA), mechanical testing, and scanning electron microscopy (SEM) and were compared with native neonatal heart valve leaflets. Fresh and cryopreserved cells showed comparable myofibroblast-like phenotypes. Genotyping confirmed their fetal origin. Neo-tissues exhibited organization, cell phenotypes, extracellular matrix production, and DNA content comparable to their native counterparts. Leaflet surfaces were covered with functional endothelia. SEM showed cellular distribution throughout the polymer and smooth surfaces. Mechanical profiles approximated those of native heart valves. Conclusions— Prenatal fetal progenitors obtained from routine chorionic villus sampling were successfully used as an exclusive, new cell source for the engineering of living heart valve leaflets. This concept may enable autologous replacements with growth potential ready for use at birth. Combined with the use of cell banking technology, this approach may be applied also for postnatal applications.Keywords
This publication has 21 references indexed in Scilit:
- Fibrin as a cell carrier in cardiovascular tissue engineering applicationsBiomaterials, 2005
- From Stem Cells to Viable Autologous Semilunar Heart ValveCirculation, 2005
- Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells☆European Journal of Cardio-Thoracic Surgery, 2005
- Strategies for the rapid prenatal diagnosis of chromosome aneuploidyEuropean Journal of Human Genetics, 2004
- The Relevance of Large Strains in Functional Tissue Engineering of Heart ValvesThe Thoracic and Cardiovascular Surgeon, 2003
- Functional Arteries Grown in VitroScience, 1999
- Tissue engineering heart valves: Valve leaflet replacement study in a lamb modelThe Annals of Thoracic Surgery, 1995
- The Safety and Efficacy of Chorionic Villus Sampling for Early Prenatal Diagnosis of Cytogenetic AbnormalitiesNew England Journal of Medicine, 1989
- Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blueBiochimica et Biophysica Acta (BBA) - General Subjects, 1986
- Aortic valve replacement with a gaged ball valveThe American Journal of Cardiology, 1962